ENDRA Life Sciences (NASDAQ:NDRA) just reported results for the second quarter of 2024.
- ENDRA Life Sciences reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -7 cents.
- The company did not report any revenue for the quarter.